Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, nominal value (euro)0.12 per share
-
Shares outstanding
-
67,811,197
-
Total 13F shares
-
12,999,810
-
Share change
-
+144,973
-
Total reported value
-
$32,108,833
-
Put/Call ratio
-
6.8%
-
Price per share
-
$2.47
-
Number of holders
-
30
-
Value change
-
+$1,060,549
-
Number of buys
-
15
-
Number of sells
-
9
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q4 2024
As of 31 Dec 2024,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,999,810 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, MORGAN STANLEY, NORTHERN TRUST CORP, RAYMOND JAMES FINANCIAL INC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), Eversept Partners, LP, BOOTHBAY FUND MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, and FRANKLIN STREET ADVISORS INC /NC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.